Backed by Amazon’s Housing Fund and Seattle Credit Union, the project will offer affordable homes near light rail while ...
Seattle-based biotech Vedana Therapeutics launched out of stealth Wednesday with a $46 million Series A round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results